AI assistant
Sending…
HALLIBURTON CO — Director's Dealing 2023
Jan 5, 2023
30269_dirs_2023-01-05_454b0999-8f5d-4517-b662-7470ac0230b0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HALLIBURTON CO (HAL)
CIK: 0000045012
Period of Report: 2023-01-03
Reporting Person: Sharp Jill D. (SVP Internal Assurance Svcs.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-01-03 | Common Stock | A | 3594 | $37.66 | Acquired | 58168.384 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to Buy Common Stock | $24.68 | 2030-01-02 | Common Stock (13103) | 13103 | Direct |
| Option to Buy Common Stock | $49.61 | 2028-01-02 | Common Stock (16733) | 16733 | Direct |
| Option to Buy Common Stock | $55.68 | 2027-01-03 | Common Stock (14197) | 14197 | Direct |
| Option to Buy Common Stock | $34.48 | 2026-01-04 | Common Stock (11649) | 11649 | Direct |
| Option to Buy Common Stock | $39.49 | 2025-01-02 | Common Stock (6653) | 6653 | Direct |
| Option to Buy Common Stock | $50.01 | 2024-01-02 | Common Stock (2900) | 2900 | Direct |
| Option to Buy Common Stock | $43.56 | 2023-05-09 | Common Stock (3840) | 3840 | Direct |
Footnotes
F1: Shares awarded pursuant to the Halliburton Company Stock and Incentive Plan. Said Plan provides for the surrender of common stock to the Issuer to satisfy withholding tax obligations.
F2: The closing price of Halliburton Company's Common Stock on the New York Stock Exchange on the January 3, 2023 grant date was $$37.66.
More from HALLIBURTON CO
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 20
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 24
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Apr 6
Proxy Solicitation & Information Statement
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 31
Director's Dealing
2026
Mar 30
Regulatory Filings
2026
Mar 27